Name
pai_1
Label
Plasminogen activator inhibitor-1 levels
Units
nanograms per milliliter
Type
numeric
Visit vs Plasminogen activator inhibitor-1 levels
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 49.2 | ± 38.8 | 37.9 | 4.3 | 224.4 | 2 | 318 |
Final | 296 | 47.8 | ± 38.3 | 37.0 | 2.4 | 227.2 | 5 | 301 |
Treatment Arm vs Plasminogen activator inhibitor-1 levels
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 49.2 | ± 38.8 | 37.9 | 4.3 | 224.4 | 2 | 318 |
HLSE | 106 | 44.9 | ± 34.6 | 38.2 | 5.7 | 196.4 | - | 106 |
HLSE-O | 104 | 51.9 | ± 42.5 | 37.4 | 5.1 | 224.4 | 2 | 106 |
HLSE-P | 106 | 50.8 | ± 39.1 | 36.7 | 4.3 | 155.3 | - | 106 |
Treatment Arm vs Plasminogen activator inhibitor-1 levels
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 296 | 47.8 | ± 38.3 | 37.0 | 2.4 | 227.2 | 4 | 300 |
HLSE | 99 | 45.5 | ± 38.7 | 34.5 | 4.7 | 227.2 | 1 | 100 |
HLSE-O | 100 | 46.5 | ± 35.0 | 37.2 | 2.4 | 156.4 | 1 | 101 |
HLSE-P | 97 | 51.6 | ± 41.2 | 40.4 | 5.4 | 199.1 | 2 | 99 |
Age vs Plasminogen activator inhibitor-1 levels
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 49.2 | ± 38.8 | 37.9 | 4.3 | 224.4 | 2 | 318 |
45-54 years | 53 | 60.7 | ± 45.5 | 49.6 | 5.7 | 224.4 | - | 53 |
55-64 years | 139 | 50.5 | ± 37.3 | 39.4 | 5.1 | 196.4 | - | 139 |
65-74 years | 120 | 42.9 | ± 36.8 | 31.0 | 4.3 | 162.3 | 1 | 121 |
75 or older | 4 | 40.2 | ± 27.5 | 29.8 | 21.4 | 79.8 | 1 | 5 |
Age vs Plasminogen activator inhibitor-1 levels
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 296 | 47.8 | ± 38.3 | 37.0 | 2.4 | 227.2 | 4 | 300 |
45-54 years | 47 | 63.7 | ± 41.7 | 61.1 | 10.1 | 199.1 | 2 | 49 |
55-64 years | 125 | 47.4 | ± 34.1 | 42.1 | 4.7 | 161.9 | 2 | 127 |
65-74 years | 119 | 42.2 | ± 40.3 | 29.9 | 2.4 | 227.2 | - | 119 |
75 or older | 5 | 43.8 | ± 19.8 | 35.8 | 29.7 | 78.7 | - | 5 |
Gender vs Plasminogen activator inhibitor-1 levels
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 49.2 | ± 38.8 | 37.9 | 4.3 | 224.4 | 2 | 318 |
Male | 234 | 47.3 | ± 36.8 | 37.3 | 4.3 | 196.4 | - | 234 |
Female | 82 | 54.6 | ± 44.0 | 42.7 | 5.9 | 224.4 | 2 | 84 |
Gender vs Plasminogen activator inhibitor-1 levels
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 296 | 47.8 | ± 38.3 | 37.0 | 2.4 | 227.2 | 5 | 301 |
Male | 219 | 45.8 | ± 36.2 | 35.8 | 5.4 | 203.5 | 3 | 222 |
Female | 77 | 53.8 | ± 43.5 | 43.0 | 2.4 | 227.2 | 2 | 79 |
Race vs Plasminogen activator inhibitor-1 levels
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 49.2 | ± 38.8 | 37.9 | 4.3 | 224.4 | 2 | 318 |
African American or Black | 40 | 36.7 | ± 29.8 | 25.3 | 6.9 | 106.1 | 2 | 42 |
Caucasian | 252 | 50.7 | ± 39.7 | 38.9 | 4.3 | 224.4 | - | 252 |
Other | 24 | 54.5 | ± 40.8 | 35.9 | 5.7 | 149.0 | - | 24 |
Race vs Plasminogen activator inhibitor-1 levels
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 296 | 47.8 | ± 38.3 | 37.0 | 2.4 | 227.2 | 4 | 300 |
African American or Black | 39 | 37.0 | ± 32.3 | 31.7 | 2.4 | 149.5 | 1 | 40 |
Caucasian | 234 | 49.4 | ± 39.6 | 38.4 | 4.7 | 227.2 | 3 | 237 |
Other | 23 | 50.5 | ± 32.3 | 45.7 | 10.1 | 140.2 | - | 23 |